FindTrial
Sign In

Effect of Ayurveda medicinein patient with sickle cell disease

Role of ayurved in reducing Sickle cell crisis and morbidity amongst known cases of SCA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034876
Enrollment
180
Registered
2021-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D573- Sickle-cell trait

Interventions

Intervention1: a Phalatrikadi kwatha b Punarnava mandur vati c Sickle cell anemia yoga d Dadimadi ghritha : a Phalatrikadi kwatha 40 ml 2 times for 6 month b Punarnava mandur vati 2 tab 2 times f

Sponsors

Ayush Govt of Gujarat
Lead Sponsor
Indian Institute of Public health
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Enlisted as SCD by GOG registry. Non pregnant women. Not suffering from any co-morbidity like HTN/DM or any other disease. Willing to participate and give written consent

Exclusion criteria

Exclusion criteria: Not enlisted as SCD by GOG registry. Pregnant women. Suffering from any co-morbidity. Not willing to participate and refuse to give written consent.

Design outcomes

Primary

MeasureTime frame
Morbidity due to sickle cell disease Sense of well being Timepoint: o month 3 month 6 month—

Secondary

MeasureTime frame
reduction in sickle cell crisis hospitalization rate Timepoint: 6 month—

Countries

India

Contacts

Public ContactDr Abhi Thaker

State model institute of Ayurveda college.

shital1811@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026